Pınar Etiz , Toygar Emre , Salih Çetiner , Adil M. Allahverdiyev
{"title":"Significance of the avidity test in IgM+/IgG+ patients infected with Toxoplasma gondii and cytomegalovirus and its relationship with demographic data","authors":"Pınar Etiz , Toygar Emre , Salih Çetiner , Adil M. Allahverdiyev","doi":"10.1016/j.diagmicrobio.2025.117126","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>IgG avidity testing is a valuable tool in distinguishing recent from past infections. This study presents a large-scale evaluation of IgG avidity test results for <em>Toxoplasma gondii</em> (toxoplasmosis) and Cytomegalovirus infections among IgM+/IgG+ patients, exploring its relationship with demographic factors with in a tertiary hospital.</div></div><div><h3>Methods</h3><div>Toxoplasma and CMV IgG/IgM levels were measured using the chemiluminescent microparticle immunoassay method. IgG avidity was assessed in IgM+/IgG+ serum samples using Micro ELISA System for <em>Toxoplasma gondii</em> and electrochemiluminescence immunoassay method for Cytomegalovirus. Avidity indices were analyzed in relation to demographic data using SPSS software.</div></div><div><h3>Results</h3><div>Between 2017 and 2024, 15,034 CMV-IgG, 20,090 CMV-IgM, and 5,693 CMV-IgG avidity tests were performed. Among 212 CMV cases analyzed for avidity (mean age 25.89 ± 26.13 years, 54.2 % male), 69.8 % had high avidity and 17.9 % had low avidity. Similarly, 14,937 Toxo-IgG, 19,895 Toxo-IgM and 4,623 Toxo-IgG avidity tests were performed. Of the 180 cases analyzed for avidity (mean age 30.01 ± 14.66 years, 85.0 % female); 70.0 % had high avidity and 15.6 % had low avidity.</div></div><div><h3>Conclusion</h3><div>In suspected Toxoplasma and CMV infections, combined IgG/IgM testing followed by IgG avidity testing is crucial for determining infection timing. Collaboration between clinicians and laboratory specialists is vital for accurate diagnosis and management, considering demographic factors.</div></div>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"114 2","pages":"Article 117126"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic microbiology and infectious disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0732889325004481","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
IgG avidity testing is a valuable tool in distinguishing recent from past infections. This study presents a large-scale evaluation of IgG avidity test results for Toxoplasma gondii (toxoplasmosis) and Cytomegalovirus infections among IgM+/IgG+ patients, exploring its relationship with demographic factors with in a tertiary hospital.
Methods
Toxoplasma and CMV IgG/IgM levels were measured using the chemiluminescent microparticle immunoassay method. IgG avidity was assessed in IgM+/IgG+ serum samples using Micro ELISA System for Toxoplasma gondii and electrochemiluminescence immunoassay method for Cytomegalovirus. Avidity indices were analyzed in relation to demographic data using SPSS software.
Results
Between 2017 and 2024, 15,034 CMV-IgG, 20,090 CMV-IgM, and 5,693 CMV-IgG avidity tests were performed. Among 212 CMV cases analyzed for avidity (mean age 25.89 ± 26.13 years, 54.2 % male), 69.8 % had high avidity and 17.9 % had low avidity. Similarly, 14,937 Toxo-IgG, 19,895 Toxo-IgM and 4,623 Toxo-IgG avidity tests were performed. Of the 180 cases analyzed for avidity (mean age 30.01 ± 14.66 years, 85.0 % female); 70.0 % had high avidity and 15.6 % had low avidity.
Conclusion
In suspected Toxoplasma and CMV infections, combined IgG/IgM testing followed by IgG avidity testing is crucial for determining infection timing. Collaboration between clinicians and laboratory specialists is vital for accurate diagnosis and management, considering demographic factors.
期刊介绍:
Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.